The first study to report that PD1 inhibition was associated with human infections was performed by Walker et al., which showed that suppression of PD1 by monoclonal antibodies increased the number of functional T cells in patients with human immunodeficiency virus (HIV) infection [100]. Here, PDCD1 is linked to HIV infectious disease.